Bone morphogenetic protein 2 gene transduction enhances the osteogenic potential of human urine-derived stem cells

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

(2014) Stéphane Palfi et al.   LANCET

BMP2 is Superior to BMP4 for Promoting Human Muscle-Derived Stem Cell-Mediated Bone Regeneration in a Critical-Sized Calvarial Defect Model

(2013) Xueqin Gao et al.   CELL TRANSPLANTATION

Virus-mediated gene delivery for human gene therapy

(2012) Mauro Giacca et al.   JOURNAL OF CONTROLLED RELEASE

Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion

(2010) Aase Bodin et al.   BIOMATERIALS

Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering

(2010) Shaofeng Wu et al.   BIOMATERIALS

Optimization of chemically defined cell culture media – Replacing fetal bovine serum in mammalian in vitro methods

(2010) J. van der Valk et al.   TOXICOLOGY IN VITRO

Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery

(2009) Ziyad S. Haidar et al.   BIOTECHNOLOGY LETTERS

Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells

(2008) Sung Eun Kim et al.   JOURNAL OF BIOMEDICAL SCIENCE

Urine Derived Cells are a Potential Source for Urological Tissue Reconstruction

(2008) Yuanyuan Zhang et al.   JOURNAL OF UROLOGY

Bone tissue engineering and repair by gene therapy

(2007) Volker et al.   Frontiers in Bioscience-Landmark